The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-04-16
DOI
10.3389/fimmu.2019.00751
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neisseria Heparin Binding Antigen is targeted by the human alternative pathway C3-convertase
- (2018) Martina Di Fede et al. PLoS One
- Structures of NHBA elucidate a broadly conserved epitope identified by a vaccine induced antibody
- (2018) Martina Maritan et al. PLoS One
- NadA3 Structures Reveal Undecad Coiled Coils and LOX1 Binding Regions Competed by Meningococcus B Vaccine-Elicited Human Antibodies
- (2018) Alessia Liguori et al. mBio
- Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Portugal
- (2017) Maria João Simões et al. PLoS One
- Serogroup B Meningococcus Outbreaks, Prevalence, and the Case for Standard Vaccination
- (2017) James Grogan et al. Current Infectious Disease Reports
- Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States
- (2017) Gowrisankar Rajam et al. mSphere
- Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study
- (2016) Sydel R Parikh et al. LANCET
- Immunogenicity of a Meningococcal B Vaccine during a University Outbreak
- (2016) Nicole E. Basta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries
- (2016) Raquel Abad et al. PLoS One
- Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined
- (2016) Massimiliano Biagini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation
- (2016) Carina Brehony et al. VACCINE
- High predicted strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in Poland
- (2016) Izabela Waśko et al. VACCINE
- Neisserial Heparin Binding Antigen (NHBA) Contributes to the Adhesion of Neisseria meningitidis to Human Epithelial Cells
- (2016) Irene Vacca et al. PLoS One
- A Large Portion of Meningococcal Antigen Typing System-Negative Meningococcal Strains from Spain Is Killed by Sera from Adolescents and Infants Immunized with 4CMenB
- (2015) R. Abad et al. Clinical and Vaccine Immunology
- Neisseria meningitidisfactor H-binding protein fHbp: a key virulence factor and vaccine antigen
- (2015) Kate L Seib et al. Expert Review of Vaccines
- MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine
- (2015) Duccio Medini et al. VACCINE
- Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine
- (2014) Georgina Tzanakaki et al. BMC MICROBIOLOGY
- Neisseria Adhesin A Variation and Revised Nomenclature Scheme
- (2014) Stefania Bambini et al. Clinical and Vaccine Immunology
- Shortcomings of pertussis vaccines: why we need a third generation vaccine
- (2014) Jan T Poolman Expert Review of Vaccines
- Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
- (2014) Robert C Read et al. LANCET
- Structure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibody
- (2014) Enrico Malito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Global Population Structure and Evolution of Bordetella pertussis and Their Relationship with Vaccination
- (2014) M. J. Bart et al. mBio
- Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials
- (2013) Timo Vesikari et al. LANCET
- Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment
- (2013) Ulrich Vogel et al. LANCET INFECTIOUS DISEASES
- Evaluation of Truncated NhhA Protein as a Candidate Meningococcal Vaccine Antigen
- (2013) Ian R. Peak et al. PLoS One
- Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage
- (2013) Giacomo Frosi et al. VACCINE
- Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)
- (2013) Julie A. Bettinger et al. VACCINE
- Conservation of Meningococcal Antigens in the Genus Neisseria
- (2013) A. Muzzi et al. mBio
- Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future
- (2013) Johan Holst et al. Human Vaccines & Immunotherapeutics
- Transcriptional Regulation of thenadAGene in Neisseria meningitidis Impacts the Prediction of Coverage of a Multicomponent Meningococcal Serogroup B Vaccine
- (2012) Luca Fagnocchi et al. INFECTION AND IMMUNITY
- Comparative Long-term Adverse Effects Elicited by Invasive Group B and C Meningococcal Infections
- (2011) M. Gottfredsson et al. CLINICAL INFECTIOUS DISEASES
- The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans
- (2011) Daniela Toneatto et al. Human vaccines & immunotherapeutics
- Structure of the C-terminal Domain ofNeisseriaHeparin Binding Antigen (NHBA), One of the Main Antigens of a Novel Vaccine againstNeisseria meningitidis
- (2011) Veronica Esposito et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy
- (2010) Jamie Findlow et al. CLINICAL INFECTIOUS DISEASES
- Review of Meningococcal Group B Vaccines
- (2010) Dan M. Granoff CLINICAL INFECTIOUS DISEASES
- Immunogenicity of 2 Investigational Serogroup B Meningococcal Vaccines in the First Year of Life
- (2010) Matthew D. Snape et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans
- (2010) Davide Serruto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines
- (2010) J. Donnelly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates
- (2009) Muriel C. Schneider et al. NATURE
- Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086
- (2008) Alessandro Mascioni et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More